All News

When people say. “It’s just $35 to see a specialist,” they miss the entire issue of cancer-related financial toxicity.

Recent research unveiled groups of patients with colorectal cancer who should undergo more frequent scans to detect disease that has spread to the lungs.

When comparing my experiences with those who came before me, I’m happy to realize that cancer treatments have gotten better and there are more Black leaders in the medical community.

I was misdiagnosed twice before receiving my kidney cancer diagnosis, and along the way, I learned the importance of expert doctors and clinical trials.

As a breast cancer survivor, I was intentional about spreading a certain messages this month: anyone can be diagnosed with breast cancer, and education about the disease could help save lives.

I know that cancer is not lighthearted but wanted to offer a fun Halloween drawing activity for those affected by the disease.

After receiving a life-changing lung cancer diagnosis, Alesha Arnold was inspired to give back to her community and improve the lives of patients with the disease.

In the depths of chemotherapy, I found myself oscillating between being gloriously present and embarrassingly permissive.

I went through two grueling bouts of cancer when I was a young adult, which drastically shaped my life.

The Food and Drug Administration will fast track the development and review of ITM-11 for the treatment of gastroenteropancreatic neuroendocrine tumors.

I was lucky to find “my person,” when dealing with cancer: someone who was experiencing similar situations as I was, even if she was thousands of miles away.

Researchers running clinical should be aware of how these new drugs affect our day-to-day lives — not just in the big ways, but also the small ones that take their toll over the long haul.

From the death of “Schitt’s Creek” Emmy winning-producer “Ben Feigin” to “Good Charlotte” signer Joel Madden donating nearly $200,000 to an osteosarcoma nonprofit, here’s what’s happening in the cancer space this week.

When I was first diagnosed with triple-negative breast cancer, I initially thought, “why me?” Now I wonder, “why not me?”

The study investigators will review the efficacy of [Lu-177]-PNT2002, a radioligand treatment, compared with Zytiga or Xtandi in patients with metastatic castration-resistant prostate cancer.

Women who face menopause after a cancer diagnosis may be able to manage their symptoms without relying on estrogen-based therapies, although discussing this with a cancer team will help patients find what’s best for them.

Brest cancer treatment was a scary experience, but thankfully a survivorship support group helped me heal.

A man shares how reading the footnote of a CT scan looking for heart disease alerted him to a mass in his right lung, leading to an unexpected diagnosis of lung cancer.

Patients with orbital indolent B-cell lymphoma, a rare type of blood cancer, may be able to have fewer side effects and less cancer treatment costs by undergoing a lower dose of radiation that still has similar responses to the standard.

CURE® surveyed its audience to learn more about what they think about Breast Cancer Awareness Month, sometimes known as “Pinktober”. Here’s what they had to say.

Cancer-related fatigue can be debilitating for many patients and survivors of cancer, but tactics like diet, exercise and other holistic approaches may provide relief for a side effect that effects every part of life.

If I put all my energy into fighting breast cancer, I’d be bringing the disease into focus every day. Instead, I’m working on outsmarting cancer.

I knew my family was close, but it wasn’t until my mom was diagnosed that I realized how bonded we truly were.

Advocacy groups helped one patient with ocular melanoma — and many others — learn more about their disease and treatment, as well as a place to connect about their experiences.

Mepitel Film skin dressings reduced rates of radiation dermatitis — a type of skin-related side effect — compared to standard of care in women undergoing radiation for breast cancer, according to recent research.

The FDA’s approval of Tecvayli was based on findings showing that 61.8% of patients with pretreated, relapsed/refractory myeloma responded to the drug.

Walking on the American Tobacco Trail has become church-like to me, as I ponder life with cancer.

The FDA granted a priority review to the oral drug quizartinib for the treatment of a form of acute myeloid leukemia, one of the more common types of leukemia.